
AD 01
CAS No. 959961-23-0
AD 01 ( —— )
产品货号. M30749 CAS No. 959961-23-0
FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称AD 01
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.
-
产品描述FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.
-
体外实验——
-
体内实验AD 01 (≥0.003 mg/kg/day, ip) exhibits significant anti-tumor activity in DU145 tumors. Animal Model:Balb-c severe compromised immuno-deficient (SCID) mice.Dosage:0.3 mg/kg/day. Administration:I,P., for 14 days.Result:Significantly lowered the tumor size.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number959961-23-0
-
分子量2703.94
-
分子式C115H187N33O42
-
纯度>98% (HPLC)
-
溶解度water:1 mg/mL
-
SMILES[H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Yakkundi et al (2013) The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway. PLoS One. 8 e55075 PMID:
产品手册




关联产品
-
Pitavastatin lactone
匹伐他汀内酯是匹伐他汀在人体中的主要代谢物。 Pitavastatin 是 HMG-CoA 还原酶的有效竞争性抑制剂,在肝微粒体中很少代谢。
-
Aristolactam I
来自马兜铃草本植物的天然化合物。
-
Lys-[Des-Arg9]Bradyk...
Lys-[Des-Arg9]Bradykinin,TFA 是内源性有效且高度选择性的缓激肽 B1 受体激动剂(人 B1 和 B2 受体的 Ki 值分别为 0.12 和 > 30000 nM)。